Rebuilding the R&D Engine in Big Pharma

被引：0

|

作者：

Green, Shawn J. ^{[1
]}

机构：

[1] Origo Biosci, Davis, CA USA

来源：

HARVARD BUSINESS REVIEW | 2008年 / 86卷 / 11期

关键词：

D O I：

暂无

中图分类号：

F [经济];

学科分类号：

02 ;

摘要：

引用

收藏

页码：129 / 129

页数：1

相关论文

共 50 条

[41] CORPORATE ENTREPRENEURSHIP IN PHARMA R&D ORGANIZATIONAL TRANSFORMATIONS
Dibirov, Murta
INNOVATION, ENTREPRENEURSHIP AND DIGITAL ECOSYSTEMS, 2016, : 610 - 622
[42] Framing the strategic R&D paradigm shift in Big Pharma: a content analysis of pharmaceutical annual reports
Schramm, Mary E.
Place, Katie R.
Laskin, Alexander V.
JOURNAL OF COMMUNICATION MANAGEMENT, 2022,
[43] R&D capital: An engine of growth?
Growiec, Jakub
ECONOMICS LETTERS, 2022, 217
[44] Taking R&D to big business
Cheung, DT
Chang, MMT
PHOTONICS SPECTRA, 2005, 39 (02) : 54 - 55
[45] Big Data and R&D Management
Holden, Greg
RESEARCH-TECHNOLOGY MANAGEMENT, 2016, 59 (05) : 22 - 26
[46] Evonik spends big on R&D
Scott, Alex
CHEMICAL & ENGINEERING NEWS, 2016, 94 (26) : 12 - 12
[47] Analysis of pharma R&D productivity - a new perspective needed
Schuhmacher, Alexander
Hinder, Markus
Stein, Alexander von Stegmann und
Hartl, Dominik
Gassmann, Oliver
DRUG DISCOVERY TODAY, 2023, 28 (10)
[48] How biotechnology changes pharma R&D: A managerial perspective
Chiesa, V. (vittorio.chiesa@unimib.it), 1600, Inderscience Publishers (05):
[49] Pharma's R&D focus shifting to stem cells
Aldridge, Susan
Genetic Engineering and Biotechnology News, 2010, 30 (13):
[50] Pharma research - AstraZeneca adds R&D jobs in US
Jarvis, Lisa
CHEMICAL & ENGINEERING NEWS, 2007, 85 (05) : 9 - 9

← 1 2 3 4 5 →